Table 1.
Age (year; mean and range) | 62.2±11.6 (3-86) | Percentage |
---|---|---|
Gender | ||
Male | 239 | 45.6% |
Female | 285 | 54.4% |
Preoperative BSCVA | ||
LP-<20/200 | 343 | 57.2% |
20/200-<20/60 | 218 | 36.3% |
20/60-20/30 | 39 | 6.5% |
≥20/25 | 0 | 0 |
Indications | ||
PCE/PBK | 261 | 43.5% |
FECD | 218 | 36.3% |
Post DSEK failed graft | 27 | 4.5% |
HSV endotheliitis-induced corneal edema | 21 | 3.5% |
ICE syndrome | 21 | 3.5% |
PPCD | 14 | 2.3% |
Post PK failed graft | 12 | 2.0% |
Post-trabeculectomy or Post-tube corneal edema | 10 | 1.7% |
Failed DMEK graft (Re-DMEK; PGF-3 and Late failure -4) | 7 | 1.2% |
Miscellaneous (Post YAG PI-4 CHED-2; ABK-2; CMV-E-1) | 9 | 1.5% |
Lens status | ||
Pseudophakic | 372 | 62% |
Phakic | 226 | 37.7% |
Aphakic | 2 | 0.3% |
Comorbidity (with one or more comorbidities) | ||
Total eyes | 91 | 15.2% |
Prior Glaucoma with or without surgery | 47 | 7.8% |
Post VR surgery (with or without SF IOL) | 12 | 2.0% |
Toxic anterior segment syndrome (TASS) | 16 | 2.7% |
Vitreous in the anterior chamber | 17 | 2.8% |
Cystoid macular edema | 17 | 2.8% |
Other known retinal pathology | 13 | 2.2% |
BSCVA – best-corrected visual acuity; LP – light perception; PCE/PBK – post-cataract corneal edema or bullous keratopathy; FECD – Fuchs’ endothelial corneal dystrophy; DSEK – Descemet stripping endothelial keratoplasty; HSV – herpes simplex virus; ICE – iridocorneal endothelial; PPCD – posterior polymorphous corneal dystrophy; PK – penetrating keratoplasty; PGF – primary graft failure; YAG – yttrium aluminum garnet; CHED – congenital hereditary endothelial dystrophy; ABK – aphakic bullous keratopathy; CMV-E – cytomegalovirus endotheliitis; VR – vitreoretinal; SF IOL – scleral fixation intraocular lens